Latest Breaking News On - Reduced attack rates - Page 1 : comparemela.com

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new analyses of real-world use of oral, once-daily ORLADEYO® (berotralstat) leading to a

United statesH james wednerBryan arnoldJohn bluthAnaheim convention centerBiocryst pharmaceuticalsWashington university school of medicineBiocryst pharmaceuticals incJohnt milliken departmentExchange commissionCryst pharmaceuticalsWashington university schoolScientific meetingAmerican collegeReduced attack ratesHereditary angioedema